iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 12-Month High – Here’s What Happened

Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $86.28 and last traded at $86.0510, with a volume of 134653 shares. The stock had previously closed at $84.81.

iShares U.S. Pharmaceuticals ETF Stock Up 1.5%

The firm has a market cap of $692.62 million, a P/E ratio of 17.75 and a beta of 0.54. The stock’s 50-day moving average is $78.90 and its 200-day moving average is $72.12.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Several hedge funds have recently made changes to their positions in IHE. Harbor Asset Planning Inc. bought a new position in iShares U.S. Pharmaceuticals ETF during the second quarter valued at about $27,000. Mather Group LLC. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $38,000. Ameriflex Group Inc. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the 3rd quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock worth $42,000 after purchasing an additional 291 shares in the last quarter. National Bank of Canada FI increased its position in shares of iShares U.S. Pharmaceuticals ETF by 42.7% during the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after purchasing an additional 175 shares during the period. Finally, CX Institutional increased its position in shares of iShares U.S. Pharmaceuticals ETF by 2,665.5% during the third quarter. CX Institutional now owns 802 shares of the company’s stock valued at $58,000 after purchasing an additional 773 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.